SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 3rd, 2018 • Biovie Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 3, 2018, between BioVie Inc., a Nevada corporation (the “Company”), Acuitas Group Holdings, LLC (“Acuitas”) and the purchasers identified on the signature pages hereto (together with Acuitas, collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANTBiovie Inc. • July 3rd, 2018 • Pharmaceutical preparations • New York
This Warrant has been issued pursuant to the terms of that certain Securities Purchase Agreement, dated as of July 3, 2018 (the “Purchase Agreement”), by and among the Company and Holder and the other Purchasers party thereto. Capitalized terms not defined herein shall have the meanings given to them in the Purchase Agreement. As used herein the following terms, unless the context otherwise requires, have the following respective meanings:
